Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Lilly to present new data on sofetabart mipitecan, olomorasib, Retevmo and Verzenio across ovarian, lung, thyroid and breast cancers at ESMO 2026


Gilead to present 28 abstracts on HIV treatment, prevention and emerging antiviral research at IDWeek 2026


Bristol Myers Squibb to present late-breaking iza-bren, pumitamig and Opdivo plus Yervoy data across solid tumours at ESMO 2026


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Do Extractable Protocols Truly Help – An End User Perspective

Presented by Ekta Mahajan, Genentech/Roche and Dr. Saskia Haehn, Laboratory Manager for Extractables & Leachables at Central Analytics of Merck KGaA, Darmstadt Germany
08th May 2019


Platform technology development for biosimilar upscaling

Presented by Dr H. Fai Poon, President, QuaCell Biotech Ltd and Floris De Smet, Sartorius Stedim Biotech
21st June 2018


Analytical Strategies for Comparability in Bioprocess Development

Presented by Dr Christine P. Chan, Ph.D., Sanofi. Followed by Joe Barco, Ph.D. Unchained Labs
28th March 2017


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia